scholarly article | Q13442814 |
P50 | author | Gyeong-Won Lee | Q91005923 |
P2093 | author name string | Sung Woo Park | |
Myoung Hee Kang | |||
Hoon-Gu Kim | |||
Se-Il Go | |||
Hankyu Jeon | |||
P2860 | cites work | Cancer immunoediting: from immunosurveillance to tumor escape | Q28212251 |
Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 s | Q33411909 | ||
VP-16 and cisplatin as first-line therapy for small-cell lung cancer | Q33445186 | ||
Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study | Q33532808 | ||
Definition and classification of cancer cachexia: an international consensus | Q34162846 | ||
Clinical pictures of malnutrition in ill elderly subjects | Q34343791 | ||
Cancer: impact of nutrition intervention outcome--nutrition issues for patients | Q34349876 | ||
Cancer cachexia, mechanism and treatment | Q34669440 | ||
New aspects of natural-killer-cell surveillance and therapy of cancer | Q34988265 | ||
Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer | Q35754078 | ||
IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse. | Q36200582 | ||
Assessing the performance of prediction models: a framework for traditional and novel measures | Q36617895 | ||
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? | Q36694116 | ||
Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone | Q36804101 | ||
Significance of Onodera's prognostic nutritional index in patients with colorectal cancer: a large cohort study in a single Chinese institution | Q36834512 | ||
STAT3 in the systemic inflammation of cancer cachexia. | Q36901910 | ||
Small cell lung cancer: have we made any progress over the last 25 years? | Q36959597 | ||
The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. | Q37080980 | ||
Pretreatment Albumin/Globulin Ratio Predicts the Prognosis for Small-Cell Lung Cancer | Q37205335 | ||
Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer | Q37205585 | ||
Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients | Q37702774 | ||
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis | Q38216183 | ||
Cancer cachexia: understanding the molecular basis. | Q38257741 | ||
Cachexia and sarcopenia: mechanisms and potential targets for intervention | Q38480042 | ||
Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer | Q38627484 | ||
TNF-α and cancer cachexia: Molecular insights and clinical implications | Q39029926 | ||
The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients | Q39070636 | ||
Impaired immune function: an early marker for cancer cachexia | Q39779914 | ||
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors | Q40752297 | ||
Prognostic nutritional index predicts prognosis in patients with metastatic nasopharyngeal carcinoma | Q41285899 | ||
Nutritional screening and early treatment of malnutrition in cancer patients | Q42117487 | ||
Prognostic nutritional index predicts outcomes of gastrectomy in the elderly | Q43489059 | ||
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years | Q43517625 | ||
Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment | Q46058203 | ||
Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. | Q47196294 | ||
Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? | Q47282777 | ||
Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer | Q48061164 | ||
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. | Q50789972 | ||
[Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients] | Q70507813 | ||
The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma | Q82794556 | ||
Nutritional predictors of postoperative outcome in pancreatic cancer | Q85226329 | ||
Low nutritional prognostic index correlates with poor survival in patients with stage IV colorectal cancer following palliative resection of the primary tumor | Q86891421 | ||
Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer | Q87853206 | ||
Onodera's Prognostic Nutritional Index as an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma | Q87937106 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1483-1491 | |
P577 | publication date | 2018-09-13 | |
P1433 | published in | Thoracic Cancer | Q26842004 |
P1476 | title | Low pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer | |
P478 | volume | 9 |
Q90669424 | Low Prognostic Nutritional Index Predicts Poor Clinical Outcomes in Patients with Stage IIIB Non-small-cell Lung Carcinoma Undergoing Chemoradiotherapy |
Q92251631 | The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Patients with Small Cell Lung Cancer Before First-Line Treatment with Etoposide and Progression-Free Survival |
Search more.